VAL-181388

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VAL-181388, covering 2024-06-10 to 2024-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants [Phase 1]